Dr. Mangelus oversees the identification and development process of all healthcare and biologic promising innovations that are candidates for commercialization. Dr. Mangelus has over 13 years of experience in the pharmaceutical industry. Before joining Ramot , Dr. Mangelus served as a program leader , taking drugs for CNS and oncology indications from early stage research to late stage clinical phases at Pharmos, Genta, and Novaremed . She is also a co-founder of PhiloGene Inc., a biotech company in the field of protein therapeutics. Miriam holds a PhD in Neurobiochemistry from Tel Aviv University and an MBA from Ben-Gurion University.